Catalent Pharma Solutions, a developer of solutions and advanced drug delivery technologies, has launched its Catalent Applied Drug Delivery Institute.
The Catalent Applied Drug Delivery Institute aspires to promote innovation, knowledge-sharing and collaboration between industry leaders, academic experts, customers and regulators to enhance understanding of available, emerging and future drug delivery technologies and improve patient care.
"The mission of the Catalent Applied Drug Delivery Institute is to bring better treatments to market by advancing the development and adoption of applied drug delivery technologies," said Kurt Nielsen, Ph.D., senior vice president of R&D, Catalent. "By harnessing the knowledge of some of the world's leading experts in drug development, delivery and formulation, the Institute will cultivate leadership and excellence in drug development through education, training and innovation."
As part of its mission, the Catalent Applied Drug Delivery Institute will serve as a link between industry and academia by providing guidance, counsel and resources on major issues pertaining to drug development, delivery and formulation. The Institute will develop programs that facilitate mutually beneficial collaborations, increase communication and shed light on regulatory issues affecting drug developers and researchers. It also will pursue a multi-tiered approach of seed funding, strategic counsel and educational programs to advance the adoption of emerging technologies.
"We hope to start an informative and productive dialog between industry and academic experts that will spur innovation at the benchtop and in the marketplace,” said Rao Tatapudy, vice president of scientific affairs, Catalent. “We look forward to a continuous series of successful collaborations as the Institute's activities unfold."
There will be a series of Institute-led initiatives designed to enhance understanding of drug delivery and inspire the next generation of science leaders. These initiatives, which will target both industry and academic audiences, will include: